Nektar Therapeutics
NKTR· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|
| Revenue | $31.15M | $21.15M | $15.78M | $45.31M |
| Net Income | -$47.66M | -$52.93M | -$37.50M | -$22.58M |
| EPS Diluted | -$0.41 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.46 |
| -$0.33 |
| -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.